Загрузка...
Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B
BACKGROUND/AIMS: Renal toxicity is a concern in patients with chronic hepatitis B taking nucleotide analogues, such as adefovir (ADV) and tenofovir disoproxil fumarate (TDF). We sought to determine the long-term renal effects of nucleotide analogue treatment versus entecavir (ETV) treatment. METHODS...
Сохранить в:
| Опубликовано в: : | Gut Liver |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Editorial Office of Gut and Liver
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7096224/ https://ncbi.nlm.nih.gov/pubmed/31060115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl18474 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|